MANCHESTER, UK — GlaxoSmithKline clinched the top prize at the IChemE 2012 Awards last week in recognition of its “radical change in the manufacture of pharmaceuticals,” the Institution of Chemical Engineers announced.
The healthcare company won the Outstanding Achievement in Chemical Engineering Award alongside project partners GEA, Siemens, Sagentia and the Universities of Newcastle, Warwick and Surrey.
RELATED: GlaxoSmithKline expands sales force in China
The winning entry, which also earned the Chemical Engineering Project of the Year Award, demonstrated that tablet production can change from stepwise and time-consuming batch processing with intermediate material transfer steps and frequent testing.
The outcome was a fully integrated and closely controlled process that ensures consistency, reducing costs by 20%, the process equipment footprint by a factor of ten and the capital cost by a factor of three.
GlaxoSmithKline also won the Health and Safety Award for its Liquid Dispensing Technology (LDT) a new tablet-manufacturing process that delivers microgramme doses with unparalleled precision and earned highly commended status in the Energy, Innovative Product and Water categories.